356 results on '"Hendricksen K"'
Search Results
2. Multidisciplinary management of muscle-invasive bladder cancer
3. Prediction of early (30-day) and late (30–90-day) mortality after radical cystectomy in a comprehensive cancer centre over two decades
4. Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial
5. High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.
6. FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy
7. Urostoma APPtimize: Improving quality of life of patients having an urostomy by offering personalised and timed guidance in a patient-centred mobile application
8. Absence de détrusor dans les tumeurs pTaHG : quel impact ?
9. Analyse multicentrique des coûts de la cystectomie radicale robot-assistée en Europe : une comparaison inter-pays
10. Perioperative complications after radical cystectomy for bladder cancer: an international multicenter collaboration
11. A comparison between intracorporeal versus extracorporeal orthotopic ileal neobladder. Results from an european multi-institutional collaboration (YAU urothelial cancer group)
12. Evaluating the impact of complications on survival outcomes in patients treated with radical cystectomy for bladder cancer. Results from an european multi-institutional collaboration (YAU urothelial cancer group)
13. 1770P Updated follow-up data and biomarker analysis of pre-operative ipilimumab and nivolumab in locoregional advanced urothelial cancer (NABUCCO)
14. Phase 2 Study of Adjuvant Intravesical Instillations of Apaziquone for High Risk Nonmuscle Invasive Bladder Cancer
15. Robot-assisted partial cystectomy versus open partial cystectomy for patients with urachal cancer
16. Impact de la récidive locale et métastatique sur la survie des patients traités par cystectomie totale ayant des marges chirurgicales positives sur les tissus mous
17. Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: a multicentre cohort from the european association of urology – young academic urologists (EAU-YAU): urothelial carcinoma working group
18. Variant histology as predictor of upstaging at radical cystectomy for urothelial bladder cancer
19. Survival outcomes after radical cystectomy versus conservative management for T1 high grade non-muscle invasive micropapillary bladder cancer: a multicentre collaboration by the European Association of Urology – young academic urologists (EAU-YAU): urothelial carcinoma working group
20. LBA31 High- vs low-dose pre-operative ipilimumab and nivolumab in locoregionally advanced urothelial cancer (NABUCCO cohort 2)
21. Comparative study of brachytherapy vs. radical cystectomy for cT1-2 muscle-invasive bladder cancer
22. Eerste resultaten van de robotcystectomie met aanleg van de urinedeviatie volgens Bricker intracorporeel: Robotcystectomie met aanleg van de urinedeviatie volgens bricker intracorporeel
23. Survival after neoadjuvant/induction combination immunotherapy versus combination platinum-based chemotherapy for stage III urothelial cancer
24. Prospective study on fdg-pet/ct for on-treatment assessment of response to neoadjuvant or induction chemotherapy in invasive bladder cancer
25. Novel classification for upper tract urothelial carcinoma to better risk-stratify patients eligible for kidney sparing strategies: an international collaborative study
26. The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
27. OC-0103 Comparative study of brachytherapy vs. radical cystectomy for cT1-2 muscle-invasive bladder cancer
28. THE IMPACT OF TREATMENT MODALITY ON SURVIVAL IN PATIENTS WITH CLINICAL NODE POSITIVE BLADDER CANCER
29. THE NECESSITY OF A SECOND TRANSURETHRAL RESECTION FOR PATIENTS DIAGNOSED WITH PTAHG TUMOR AT FIRST TUR: A MULTICENTER COLLABORATION OF EAU YOUNG ACADEMIC UROLOGISTS UROTHELIAL CARCINOMA GROUP
30. False-positive lesions detected by fluorescence cystoscopy: any association with p53 and p16 expression?
31. Défaut d’adoption de l’instillation intravésicale postopératoire précoce de chimiothérapie après néphro-urétérectomie totale
32. Diagnostic laparoscopy and abdominal cytology detect peritoneal metastases in patients with urachal adenocarcinoma
33. Intravesical chemohyperthermia (HIVEC-E) in BCG unresponsive non-muscle invasive bladder cancer patients: Oncological outcomes of a multi-centre European registry
34. Shared decision making and study participation in renal cancer care; the value of centralized multidisciplinary team consultation of the Amsterdam Renal Cancer Network
35. No impact on disease recurrence or progression of the stage at re-TUR in Ta high-grade bladder cancer patients treated with BCG: A multi-center collaboration of EAU Young Academic Urologists Urothelial Carcinoma Group
36. Clinical impact of [18F] Fluorodeoxyglucose positron emission tomography/computed tomography on management of patients with muscle-invasive bladder cancer
37. Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy
38. Outcome after resection of isolated single- or oligometastatic lymph node metastases at the time of nephrectomy
39. Feasibility and efficacy of preoperative ipilimumab/nivolumab in loco-regionally advanced urothelial cancer of the bladder (NABUCCO)
40. Safety and Side Effects of Immediate Instillation of Apaziquone Following Transurethral Resection in Patients With Nonmuscle Invasive Bladder Cancer
41. Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis
42. P160 - Urostoma APPtimize: Improving quality of life of patients having an urostomy by offering personalised and timed guidance in a patient-centred mobile application
43. SC121 - Perioperative complications after radical cystectomy for bladder cancer: an international multicenter collaboration
44. SC126 - Evaluating the impact of complications on survival outcomes in patients treated with radical cystectomy for bladder cancer. Results from an european multi-institutional collaboration (YAU urothelial cancer group)
45. SC117 - A comparison between intracorporeal versus extracorporeal orthotopic ileal neobladder. Results from an european multi-institutional collaboration (YAU urothelial cancer group)
46. Konditionelle Regressionsanalysen von Rezidiv- und Progressions-Wahrscheinlichkeit bei Patienten mit nicht-muskelinvasiven TaG1 Blasentumor
47. Prediction of early (30-day) and late (30–90-day) mortality after radical cystectomy in a comprehensive cancer centre over two decades
48. Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy
49. Adjuvant chemotherapy improves survival outcomes in patients treated with neoadjuvant chemotherapy and radical cystectomy for bladder cancer: Results of a multi-institutional collaboration
50. Pre-operative ipilimumab and nivolumab in locoregionally advanced, stage III, urothelial cancer (NABUCCO)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.